| 000 | 01882 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515013753.0 | ||
| 264 | 0 | _c20060307 | |
| 008 | 200603s 0 0 eng d | ||
| 022 | _a1097-6787 | ||
| 024 | 7 |
_a10.1016/j.jaad.2004.11.060 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWilkins, Karl | |
| 245 | 0 | 0 |
_aCutaneous malignancy and human immunodeficiency virus disease. _h[electronic resource] |
| 260 |
_bJournal of the American Academy of Dermatology _cFeb 2006 |
||
| 300 |
_a189-206; quiz 207-10 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAlgorithms |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAnti-Retroviral Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aAnus Neoplasms _xepidemiology |
| 650 | 0 | 4 |
_aCarcinoma, Basal Cell _xepidemiology |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xepidemiology |
| 650 | 0 | 4 |
_aHIV Infections _xdrug therapy |
| 650 | 0 | 4 |
_aHerpesviridae Infections _xepidemiology |
| 650 | 0 | 4 |
_aHerpesvirus 8, Human _xisolation & purification |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunity, Cellular |
| 650 | 0 | 4 | _aImmunohistochemistry |
| 650 | 0 | 4 |
_aLymphoma, Large-Cell, Anaplastic _xepidemiology |
| 650 | 0 | 4 |
_aLymphoma, T-Cell, Cutaneous _xepidemiology |
| 650 | 0 | 4 |
_aMelanoma _xepidemiology |
| 650 | 0 | 4 | _aPapillomaviridae |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xepidemiology |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 |
_aSarcoma, Kaposi _xdrug therapy |
| 650 | 0 | 4 | _aSeroepidemiologic Studies |
| 650 | 0 | 4 |
_aSkin Neoplasms _xepidemiology |
| 700 | 1 | _aTurner, Ryan | |
| 700 | 1 | _aDolev, Jacqueline C | |
| 700 | 1 | _aLeBoit, Philip E | |
| 700 | 1 | _aBerger, Timothy G | |
| 700 | 1 | _aMaurer, Toby A | |
| 773 | 0 |
_tJournal of the American Academy of Dermatology _gvol. 54 _gno. 2 _gp. 189-206; quiz 207-10 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jaad.2004.11.060 _zAvailable from publisher's website |
| 999 |
_c16057368 _d16057368 |
||